Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CML

Leukemia

Volumn 12, Issue 3, 1998, Pages 333-339

  Heinzinger, M ^a,b   Waller, C F ^a   Rosenstiel, A ^a   Scheid, S ^a   Burger, K J ^c   Lange, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Firma Sandoz   (Germany)

Author keywords

Autologous transplantation; Bcr abl; CML; PBPC; rhG CSF; rhIL 3

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERLEUKIN 3;

ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HEMATOPOIETIC STEM CELL; HUMAN; LEUKAPHERESIS; MALE; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031930236     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400960     Document Type: Article

References (27)

1. Rowley JD. The Philadelphia chromosome translocation: a paradigm for understanding leukemia. Cancer 1990; 65: 2178-2184.
2. Heisterkamp N, Stephensen JR, Grotten J, Hansen PF, de Klein A, Bartram CR, Grosveld C. Localization of the c-abl oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 1983; 306: 239-242.
3. Daley GQ, Van Etten RA, Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824-830.
4. McGlave P, Verfaillie C, Miller J. Chronic myelogenous leukemia: in search of the benign hematopoietic stem cell. Stem Cells 1993; 11: 10-13.
5. Snyder DS, McGlave PB. Treatment of chronic myelogenous leukemia with bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 535-557.
6. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia Philadelphia chromosome-positive patients. Ann Intern Med 1991; 114: 532-538.
7. Weisdorf D, Haake R, Blazar R, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A. Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 1991; 51: 1197-1203.
8. Brito-Babapulle F, Bowock SJ, Marcus RE, Apperley J, Theng KH, Dowding C, Rassol F, Guo AP, Catovsky D, Galton DA. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. Br J Haematol 1989; 73: 76-81.
9. Reiffers J, Trouette R, Marit G, Montastruc M, Faberes C, Cony-Makhoul P, David B, Bourdeau MJ, Bilhou-Nabera C, Lacombe F. Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Br J Haematol 1991; 77: 339-345.
10. Barnett MJ, Eaves CJ, Phillips CL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann HG, Lansdorp PM, Nantel SH, Reece DE, Shephered JD, Spinelli JJ, Sutherland HJ, Eaves AC: autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 1994; 84: 724-732.
11. Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-271.
12. Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I, Przepiorka D, Van Besien K, Andersson B, Mehra R, Gajewski J, Seong D, Hester J, Estey E, Korbling M, Pollicardo N, Berenson R, Heimfeld S, Champlin R, Deisseroth B. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood 1995; 85: 3257-3263.
13. Kirk JA, Reems JA, Roecklein BA, Van Devanter DR, Bryant EM, Radich J, Edmands S, Lee A, Torok-Storb B. Benign marrow progenitors are enriched in the CD34+/HLA-DRlo population but not in the CD34+/CD38lo population in chronic myeloid leukemia: an analysis using interphase fluorescence in situ hybridization. Blood 1995; 86: 737-743.
14. Verfaillie CM, Miller WJ, Boylan K, McGlave PB. Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 1992; 79: 1003-1010.
15. Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Bcr/Abl-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients. Blood 1996; 87: 4770-4779.
16. Brugger W, Birken R, Bertz H, Hecht T, Pressler K, Frisch J, Schulz G, Mertelsmann R, Kanz L. Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin. Br J Haematol 1993; 84: 402-407.
17. Dewald GW, Broderick DJ, Tom WW, Hagstrom JE, Pierre RV. The efficacy of direct, 24-hour culture, and mitotic synchronization methods for cytogenetic analysis of bone marrow in neoplastic hematologic disorders. Cancer Genet Cytogenet 1985; 18: 1-10.
18. Kawasaki ES, Clark SS, Coyne MY, Smith SD, Champlin R, Witte ON, McCormick FP. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988; 85: 5698-5702.
19. Lange W, Herkert R, Finke J, Ragoczy U, Siegert W, Mertelsmann R, Dölken G. Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation. Ann Hematol 1991; 63: 189-194.
20. Torlakovic E, Litz CE, McClure JS, Brunning RD. Direct detection of the Philadelphia chromosome in CD20-positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 1994; 8: 1940-1943.
21. Podesta M, Piaggio G, Frassoni F, Sessarego M, Benvenuto F, Figari O, Pitto A, Vassallo F, Soracco M, Pollicardo N, Pungolino E, Gatti A, Prencipe E, Carella AM. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML). Bone Marrow Transplant 1995; 16: 549-555.
22. Bedi A, Zehnbauer BA, Collector MI, Barber JP, Zicha MS, Sharkis SJ, Jones RJ. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood 1993; 81: 2898-2902.
23. Keating A, Wang XH, Laraya P. Variable transcription of BCR-ABL by Ph+ cells arising from hematopoietic progenitors in chronic myeloid leukemia. Blood 1994; 83: 1744-1749.
24. Thijsen SFT, Shuurhuis GJ, van Oostveen JW, Theijsmeijer AP, Langenhuijsen MMAC, Ossenkoppele GJ. Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR. Leukemia 1997; 11: 301-305.
25. Eaves C. Future use of growth factors to improve the treatment of leukaemia using strategies that require haematological rescue. In: Metcalf D, Borden EC (eds). Therapeutic Strategies in Oncology, Haematopoietic growth factors and the Treatment of Myeloid Leukaemias. Mediscript: London, 1991, pp 27-50.
26. Carella AM, Cunningham I, Lerma E, Dejana A, Benvenuto F, Podesta M, Celesti L, Chimirri F, Abate M, Vassallo F, Figari O, Parodi C, Sessarego M, Valbonesi M, Carlier P, Prencipe E, Gatti AM, Van Den Berg D, Hoffman R, Frassoni F. Mobilization and transplantation of Philadelphia-negative peripheral blood progenitor cells early in chronic myelogenous leukemia. J Clin Oncol 1997; 15: 1575-1582.
27. Lange W, Cantin EM, Finke J, Dolken G. In vitro and in vivo effects of synthetic ribozymes targeted against BCR/ABL mRNA. Leukemia 1993; 7: 1786-1794.